CMPX
Price
$2.56
Change
-$0.13 (-4.83%)
Updated
Jun 27 closing price
Capitalization
354M
30 days until earnings call
SAVA
Price
$1.83
Change
+$0.08 (+4.57%)
Updated
Jun 30, 03:23 PM (EDT)
Capitalization
84.54M
30 days until earnings call
Interact to see
Advertisement

CMPX vs SAVA

Header iconCMPX vs SAVA Comparison
Open Charts CMPX vs SAVABanner chart's image
Compass Therapeutics
Price$2.56
Change-$0.13 (-4.83%)
Volume$3.01M
Capitalization354M
Cassava Sciences
Price$1.83
Change+$0.08 (+4.57%)
Volume$200
Capitalization84.54M
CMPX vs SAVA Comparison Chart in %
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. SAVA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Buy and SAVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CMPX: $2.56 vs. SAVA: $1.77)
Brand notoriety: CMPX and SAVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 355% vs. SAVA: 541%
Market capitalization -- CMPX: $354M vs. SAVA: $84.54M
CMPX [@Biotechnology] is valued at $354M. SAVA’s [@Biotechnology] market capitalization is $84.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileSAVA’s FA Score has 1 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • SAVA’s FA Score: 1 green, 4 red.
According to our system of comparison, SAVA is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while SAVA’s TA Score has 3 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 4 bearish.
  • SAVA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CMPX is a better buy in the short-term than SAVA.

Price Growth

CMPX (@Biotechnology) experienced а +6.67% price change this week, while SAVA (@Biotechnology) price change was -11.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.65%. For the same industry, the average monthly price growth was +32.92%, and the average quarterly price growth was +6.78%.

Reported Earning Dates

CMPX is expected to report earnings on Jul 30, 2025.

SAVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($354M) has a higher market cap than SAVA($84.5M). CMPX YTD gains are higher at: 76.552 vs. SAVA (-25.000). CMPX has higher annual earnings (EBITDA): -60.17M vs. SAVA (-145.89M). SAVA (117M) and CMPX (113M) have equal amount of cash in the bank . SAVA has less debt than CMPX: SAVA (0) vs CMPX (6.38M). CMPX has higher revenues than SAVA: CMPX (850K) vs SAVA (0).
CMPXSAVACMPX / SAVA
Capitalization354M84.5M419%
EBITDA-60.17M-145.89M41%
Gain YTD76.552-25.000-306%
P/E RatioN/AN/A-
Revenue850K0-
Total Cash113M117M97%
Total Debt6.38M0-
FUNDAMENTALS RATINGS
SAVA: Fundamental Ratings
SAVA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXSAVA
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+4.44%
Oncotelic Therapeutics, Inc.
CKHGY97.521.78
+1.86%
Capitec Bank Holdings Ltd
HRIBF61.03N/A
N/A
Horiba Ltd.
KCLI31.88N/A
N/A
Kansas City Life Insurance Co.
DNQUF10.42N/A
N/A
Denali Capital Acquisition Corp

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VIR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-1.54%
VIR - CMPX
38%
Loosely correlated
-2.64%
SANA - CMPX
36%
Loosely correlated
N/A
TRDA - CMPX
36%
Loosely correlated
-1.57%
MGNX - CMPX
35%
Loosely correlated
-6.30%
FHTX - CMPX
34%
Loosely correlated
-0.41%
More

SAVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with PRRUF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
-3.28%
PRRUF - SAVA
33%
Loosely correlated
N/A
OMER - SAVA
25%
Poorly correlated
-3.61%
CMPX - SAVA
23%
Poorly correlated
-1.54%
RARE - SAVA
22%
Poorly correlated
-2.43%
IDYA - SAVA
22%
Poorly correlated
-4.13%
More